Oxford Textbook of Colorectal Cancer examines the disease from epidemiology and molecular development through diagnosis, multidisciplinary treatment, and survivorship. Edited by Rachel S. Kerr, Li Yang, and David J. Kerr, it connects tumor biology with clinical decisions. The volume is intended for oncology trainees, specialist clinicians, and researchers studying colorectal cancer care.
Digital ebook. Checkout sends an order request.
The biological discussion follows pathways from normal epithelium to malignancy, including the adenoma-carcinoma sequence, molecular subtypes, genomic instability, and the tumor microenvironment. Epidemiology and screening place these mechanisms within a wider account of how colorectal cancer develops and is detected. Chapters connect underlying science with questions encountered in clinical work.
Treatment coverage brings surgery, radiotherapy, chemotherapy, targeted agents, and immunotherapy into a multidisciplinary framework. Minimally invasive procedures and metastatic disease are considered alongside follow-up, quality of life, and survivorship. The book gives trainees a structured route through interconnected subjects and offers specialists material for reviewing the contributions of different disciplines. Researchers can examine how biological findings relate to the treatment approaches discussed in the volume.
Kerr, Yang, and Kerr follow colorectal cancer from its molecular origins through screening, diagnosis, treatment, and life after treatment. The volume keeps tumor biology and clinical decisions in the same frame, showing how a multidisciplinary team assembles surgery, radiotherapy, systemic therapy, and supportive care.
The book begins with how colorectal cancer develops. The adenoma-carcinoma sequence, molecular subtypes, genomic instability, and the tumor microenvironment are described as mechanisms that shape the disease. Epidemiology and screening then place those mechanisms in a population context. Diagnosis and staging connect findings to treatment decisions. The therapeutic sections bring surgery, radiotherapy, chemotherapy, targeted agents, and immunotherapy into a multidisciplinary plan, with minimally invasive procedures and metastatic disease given their own attention. Later chapters address follow-up, quality of life, and survivorship, so the volume does not stop at treatment. Trainees gain a sequence through connected subjects, and specialists can review how disciplines contribute.
Population-level patterns and screening programs frame the clinical material. The book situates colorectal cancer within a wider account of who develops it and how it is detected. Screening is treated as a pathway into earlier diagnosis.
The biological section follows the path from normal epithelium to malignancy. The adenoma-carcinoma sequence, molecular subtypes, genomic instability, and the tumor microenvironment are used to explain differences in behavior. These mechanisms recur when treatment is discussed.
Diagnosis translates symptoms and findings into a defined problem. Staging then establishes how far the disease has progressed, which determines the treatment options. The text keeps that link explicit so the biology informs clinical choices.
Treatment is presented as a combined effort rather than a single modality. Surgery, radiotherapy, chemotherapy, targeted agents, and immunotherapy each have a role, and coordination determines the plan. Minimally invasive procedures sit within that larger framework.
Metastatic disease receives separate treatment because its management differs from localized cancer. The book considers how the available modalities are applied when the disease has spread. Biology and clinical judgment meet again in these decisions.
The volume continues past active treatment into follow-up and survivorship. Quality of life and long-term care are treated as legitimate parts of the disease journey. This closing material broadens the definition of successful management.
Oncology trainees, specialist clinicians, and researchers studying colorectal cancer care who want an integrated view of biology, diagnosis, treatment, and survivorship.
Edition, audience, and study-guide details at a glance.
Oxford Textbook of Colorectal Cancer examines the disease from epidemiology and molecular development through diagnosis, multidisciplinary treatment, and survivorship. Edited by Rachel S. Kerr, Li Yang, and David J. Kerr, it connects tumor biology with clinical decisions. The volume is intended for oncology trainees, specialist clinicians, and researchers studying colorectal cancer care.
Oncology trainees, specialist clinicians, and researchers studying colorectal cancer care who want an integrated view of biology, diagnosis, treatment, and survivorship.
Yes. This page includes an original study guide with six thematic sections, key takeaways, and a topic map for structured reading.
More books from this subject area.
